Endothelium-Restricted Endothelin-1 Overexpression In Type 1 Diabetes Worsens Atherosclerosis And Immune Cell Infiltration Via Nox1

Aims NADPH oxidase (NOX) 1 but not NOX4-dependent oxidative stress plays a role in diabetic vascular disease, including atherosclerosis. Endothelin (ET)-1 has been implicated in diabetes-induced vascular complications. We showed that crossing mice overexpressing human ET-1 selectively in endothelium (eET-1) with apolipoprotein E knockout (Apoe(-/-)) mice enhanced high-fat diet-induced atherosclerosis in part by increasing oxidative stress. We tested the hypothesis that ET-1 overexpression in the endothelium would worsen atherosclerosis in type 1 diabetes through a mechanism involving NOX1 but not NOX4.Methods and results Six-week-old male Apoe(-/-) and eET-1/Apoe(-/-) mice with or without Nox1 (Nox1(-/y)) or Nox4 knockout (Nox4(-/-)) were injected intraperitoneally with either vehicle or streptozotocin (55 mg/kg/day) for 5 days to induce type 1 dia betes and were studied 14weeks later. ET-1 overexpression increased 2.5-fold and five-fold the atherosclerotic lesion area in the aortic sinus and arch of diabetic Apoe(-/-) mice, respectively. Deletion of Nox1 reduced aortic arch plaque size by 60%; in contrast, Nox4 knockout increased lesion size by 1.5-fold. ET-1 overexpression decreased aortic sinus and arch plaque alpha smooth muscle cell content by similar to 35% and similar to 50%, respectively, which was blunted by Nox1 but not Nox4 knockout. Reactive oxygen species production was increased two-fold in aortic arch perivascular fat of diabetic eET-1/Apoe(-/-) and eET-1/Apoe(-/-)/Nox4(-/-) mice but not eET-1/Apoe(-/-)/Nox1(y/-) mice. ET-1 overexpression enhanced monocyte/macrophage and CD3(+) T-cell infiltration similar to 2.7-fold in the aortic arch perivascular fat of diabetic Apoe(-/-) mice. Both Nox1 and Nox4 knockout blunted CD3(+ )T-cell infiltration whereas only Nox1 knockout prevented the monocyte/macrophage infiltration in diabetic eET-1/Apoe(-/-) mice.Conclusion Endothelium ET-1 overexpression enhances the progression of atherosclerosis in type 1 diabetes, perivascular oxidative stress, and inflammation through NOX1.[GRAPHICS].